CAR T cells targeting podoplanin reduce orthotopic glioblastomas in mouse brains S Shiina, M Ohno, F Ohka, S Kuramitsu, A Yamamichi, A Kato, ... Cancer immunology research 4 (3), 259-268, 2016 | 105 | 2016 |
Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses S Kuramitsu, M Ohno, F Ohka, S Shiina, A Yamamichi, A Kato, ... Cancer gene therapy 22 (10), 487-495, 2015 | 67 | 2015 |
Tumor antigens in glioma T Nejo, A Yamamichi, ND Almeida, YE Goretsky, H Okada Seminars in immunology 47, 101385, 2020 | 49 | 2020 |
Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma L Chalise, A Kato, M Ohno, S Maeda, A Yamamichi, S Kuramitsu, S Shiina, ... Molecular Therapy-Oncolytics 26, 265-274, 2022 | 44 | 2022 |
Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion A Yamamichi, F Ohka, K Aoki, H Suzuki, A Kato, M Hirano, K Motomura, ... Brain Tumor Pathology 35, 106-113, 2018 | 21 | 2018 |
A novel all-in-one intraoperative genotyping system for IDH1-mutant glioma F Ohka, A Yamamichi, M Kurimoto, K Motomura, K Tanahashi, H Suzuki, ... Brain tumor pathology 34, 91-97, 2017 | 21 | 2017 |
Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma P Chuntova, A Yamamichi, T Chen, R Narayanaswamy, S Ronseaux, ... Journal for immunotherapy of cancer 10 (5), 2022 | 17 | 2022 |
A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR M Hirano, F Ohka, S Maeda, L Chalise, A Yamamichi, K Aoki, A Kato, ... Brain Tumor Pathology 35, 97-105, 2018 | 14 | 2018 |
An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas A Yamamichi, T Kasama, F Ohka, H Suzuki, A Kato, K Motomura, ... Science and technology of advanced materials 17 (1), 618-625, 2016 | 14 | 2016 |
Remote ischemic preconditioning protects human neural stem cells from oxidative stress A Motomura, M Shimizu, A Kato, K Motomura, A Yamamichi, H Koyama, ... Apoptosis 22, 1353-1361, 2017 | 12 | 2017 |
Aberrant active cis-regulatory elements associated with downregulation of RET finger protein overcome chemoresistance in glioblastoma M Ranjit, M Hirano, K Aoki, Y Okuno, F Ohka, A Yamamichi, A Kato, ... Cell Reports 26 (9), 2274-2281. e5, 2019 | 11 | 2019 |
Adoptive immunotherapy for the treatment of glioblastoma: Progress and possibilities S Kuramitsu, A Yamamichi, F Ohka, K Motomura, M Hara, A Natsume Immunotherapy 8 (12), 1393-1404, 2016 | 11 | 2016 |
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas T Nishikawa, R Watanabe, Y Kitano, A Yamamichi, K Motomura, F Ohka, ... Brain Tumor Pathology, 1-11, 2022 | 10 | 2022 |
Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice P Chuntova, Y Hou, R Naka, A Yamamichi, T Chen, Y Goretsky, R Hatae, ... Neuro-oncology 24 (2), 259-272, 2022 | 8 | 2022 |
Rapid sensitive analysis of IDH1 mutation in lower-grade gliomas by automated genetic typing involving a quenching probe M Kurimoto, H Suzuki, K Aoki, F Ohka, G Kondo, K Motomura, K Iijima, ... Cancer investigation 34 (1), 12-15, 2016 | 8 | 2016 |
Immunotherapy approaches in isocitrate-dehydrogenase-mutant low-grade glioma M Gallus, D Kwok, S Lakshmanachetty, A Yamamichi, H Okada Cancers 15 (14), 3726, 2023 | 7 | 2023 |
Pathogenic epigenetic consequences of genetic alterations in IDH-Wild-Type diffuse astrocytic gliomas F Ohka, K Shinjo, S Deguchi, Y Matsui, Y Okuno, K Katsushima, M Suzuki, ... Cancer research 79 (19), 4814-4827, 2019 | 7 | 2019 |
Glioma-neuronal circuit remodeling induces regional immunosuppression T Nejo, S Krishna, C Jimenez, A Yamamichi, JS Young, ... bioRxiv, 2023.08. 04.548295, 2023 | 5 | 2023 |
CAR T cells targeting podoplanin reduce orthotopic glioblastomas in mouse brains. Cancer Immunol Res.(2016) 4: 259–68. doi: 10.1158/2326-6066 S Shiina, M Ohno, F Ohka, S Kuramitsu, A Yamamichi, A Kato CIR-15-0060, 0 | 5 | |
Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens DW Kwok, NO Stevers, T Nejo, LH Chen, I Etxeberria, J Jung, K Okada, ... bioRxiv, 2023.10. 19.563178, 2023 | 3 | 2023 |